Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle

Yvette Brockwell, Timothy P. Elliot, Glenn Anderson, Rex Stanton, Terry Spithill, Nicholas Sangster

Research output: Contribution to journalArticlepeer-review

61 Citations (Scopus)
16 Downloads (Pure)

Abstract

Triclabendazole (TCBZ) is the drug of choice for Fasciola hepatica control and reports of F. hepatica resistant to this drug from a wide range of geographic regions are very concerning. This study investigated the presence of TCBZ resistance in F. hepatica in naturally infected Australian beef and dairy cattle herds and evaluated methods of measuring the levels of resistance. Faecal egg count and coproantigen reduction tests (FECRT and CRT, respectively) were conducted on 6 South-eastern Australian beef properties and one dairy property where treatment failure by triclabendazole (TCBZ) was suspected. The CRT was conducted on an additional beef property. On each property 15 animals were treated with an oral preparation of TCBZ at the recommended dose and 15 animals remained as untreated controls. Fluke eggs in faeces were counted and coproantigen levels were measured before treatment and 21 days after treatment and in the untreated control animals. These data were evaluated using three different methods to calculate % reductions compared with controls. Resistance (<90% reduction) was detected on the dairy property using both FEC and CRT, and on 3/6 beef properties using FECRT and 4/7 beef properties using CRT. Using the FECRT, reductions of 6.1â€Â'14.1% were observed in dairy cattle and 25.9â€Â'65.5% in beef cattle. Using the CRT, reductions of 0.4â€Â'7.6% were observed in dairy cattle and 27.0â€Â'69.5% in beef cattle. Live flukes were recovered at slaughter following TCBZ treatment of 6 cattle from 3 of the beef properties, confirming the TCBZ resistance status of F. hepatica in these cattle. This is the first report of F. hepatica resistant to TCBZ in cattle in Australia and the results suggest that resistance is widespread in the South-eastern region. The CRT is shown to be a robust alternative to the FECRT for evaluation of TCBZ resistance in F. hepatica in cattle.
Original languageEnglish
Pages (from-to)48-54
Number of pages7
JournalInternational Journal for Parasitology: Drugs and Drug Resistance
Volume4
Issue number1
DOIs
Publication statusPublished - Apr 2014

Fingerprint Dive into the research topics of 'Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle'. Together they form a unique fingerprint.

Cite this